FDA Approves First COVID-19 Treatment for Young Children: Remdesevir

"U.S. Food and Drug Administration expanded the approval of the COVID-19 treatment Veklury (remdesivir) to include pediatric patients 28 days of age and older weighing at least 3 kilograms (about 7 pounds) with positive results of direct SARS-CoV-2 viral testing, who are:

• Hospitalized, or
• Not hospitalized and have mild-to-moderate COVID-19 and are at high risk for progression to severe COVID-19, including hospitalization or death. "

Coronavirus (COVID-19) Update: FDA Approves First COVID-19 Treatment for Young Children | FDA